VX PHARMA (U.K.) LTD
Significant control: Mark Fyvie (25–50%), Donald Anthony Ewer (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
What does Vx Pharma (U.K.) Ltd sell?
Registered activity: Other professional, scientific and technical activities n.e.c. (SIC 74909). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
VX PHARMA (U.K.) LTD is an active private limited company (company number 13168453) incorporated on 29 January 2021, registered in Oxford. Its registered activity is other professional, scientific and technical activities n.e.c. (SIC 74909). Latest micro accounts cover the period ending 31 January 2025, showing net assets of £32k, with 2 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 9% on the prior period (£29k).
By net assets it sits in the upper half of 644 comparable companies in Oxford (median £9,763, upper quartile £74k).
Ownership and control
- Dr. Mark Fyvie
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Mr Donald Anthony Ewer
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 29 January 20215 yrs ago
- Next accounts due
- 31 October 2026in 8 days
- Confirmation statement due
- 12 February 2027in 112 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 74909
- Other professional, scientific and technical activities n.e.c.
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 January 2025 | £32k | — | — | £10k | — | — | 2 |
| 31 January 2024 | £29k | — | — | £8,395 | — | — | 2 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets above zeroNet assets £32,149 at 31 January 2025
- Current assets below creditors within one yearCurrent ratio 0.06
- Incorporated five or more years agoIncorporated 29 January 2021
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 112 days
- Next accounts duein 8 days
- Accounts period endNet assets £32k · micro accounts
- Accounts period endNet assets £29k · micro accounts
- Incorporated
Similar companies in Oxford
- BENTLEY GILBERT ASSOCIATES LTDWantage · inc. Jan 2021
- BIOTECH HEATING SERVICES LIMITEDBanbury · inc. Jan 2021
- ANIMADE GROUP LIMITEDThame · inc. Jan 2021
- NEVERMIND AI LTDOxford · inc. Jan 2021
- ZAYNA LTDBletchingdon · inc. Mar 2021
- PATTRN ANALYTICS AND INTELLIGENCE LTDOxford · inc. Mar 2021
All companies incorporated on 29 January 2021 · in Jan 2021.
Reminders for VX PHARMA (U.K.) LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.